Aristotle University Of Thessaloniki (AUTH)
Νατριουρητικά πεπτίδια και καρδιακή λειτουργία σε ασθενείς με σακχαρώδη διαβήτη τύπου 2
Abstract
dc:descriptionBackground: Diabetes is associated with a twofold to fivefold increase in the risk of heart failure, independent of hypertension, body mass index or coronary disease. The American College of Cardiology-American Heart Association recommendations for diagnosis and management of heart failure classify patient who have diabetes (but no obvious myocardial structural abnormalities) as stage A «pre-heart failure» patients and urge clinicians to try to prevent the development of overt or manifest LV systolic and diastolic dysfunction. Aims: To assess early pre-clinical heart dysfunction of type-2 diabetic patients using the biochemical markers ANP and BNP together with the echocardiography Myocardial Performance Index (MPI, TEI index). Methods: We studied a cohort of 44 asymptomatic randomly recruited type-2 diabetic patients who were free of a history of heart failure, coronary artery disease. The patients we evaluated by clinical examination and Doppler echocardiography studies with special emphasis to Myocardial Performance Index (TEI index). BNP, ANP and HbA1c were measured. We investigated the correlation between BNP and TEI index, ANP and TEI index, BNP and HbA1c, TEI index and HbA1c, ANP and HbA1c. Results: Log TEI index correlated with log BNP (r²=0,453, p<0,001). Log TEI index correlated with HbA1c (r²=0,226 p<0,014) and log BNP correlated with HbA1c (r²=0,258, p<0,008). No statistically significant correlation was found between ANP and TEI index, ANP and HbA1c. Conclusions: In asymptomatic type-2 diabetic patients free of heart disease there is a strong correlation between BNP and TEI index and there values tend to be higher than the normal reference values. Both BNP and TEI index are considered to be sensitive subclinical markers that their increased values imply an ongoing myocardial dysfunction. Both markers offer remarkable opportunity for an early recognition of ventricular dysfunction of a pre-clinical stage permitting early therapeutic intervention with the potential to postpone or potentially keep free of complications the patients. We anticipate that both markers will become clinically established in the near future offering new diagnostic and therapeutic perspectives.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Fotiadis, Spyridon
- Φωτιάδης, Σπυρίδων
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19584